๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ethnic differences in risk and prognostic factors for breast cancer

โœ Scribed by Stephanie E. Weiss; Paul I. Tartter; Sharmila Ahmed; Steven T. Brower; Cristina Brusco; Kathy Bossolt; James B. Amberson; Joan Bratton


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
594 KB
Volume
76
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background. Poor survival among African American patients with breast cancer has been attributed to low so- cioeconomic status and lack of access to health care. However, Hispanics of equivalent socioeconomic status and health care access exhibit much higher survival rates, almost comparable to whites. This suggests that biologic differences play a role in differences in breast cancer survival in addition to socioeconomic and health care access factors.

Methods. The authors studied clinical and molecular differences between patients with breast cancer of different ethnicity to determine biologic explanations for the observed differences in survival. Consecutive patients scheduled for breast biopsies were identified preoperatively and were interviewed. Blood was withdrawn for serum marker measurements, and tumor specimens collected at frozen section diagnosis were analyzed by flow cytometry, hormone receptor concentration, tumor grade, and Ki-67 nuclear antigen, HER-2/neu, and epidermal growth factor oncoprotein expression.

Results. Age, age at menarche, number of lymph nodes with metastasis, estrogen and progesterone receptor levels, ploidy status, S-phase, Ki-67, HER-2/neu expression, tumor grade, epidermal growth factor receptor expression, lipid-associated sialic acid (LASA), and carcinoembryonic antigen level were not significantly related to ethnicity. African Americans presented at a significantly more advanced stage and with significantly larger tumors. They were significantly heavier and had a significantly higher mean Quetelet's index and a significantly higher number of pregnancies and number of live births. Whites and Hispanics were significantly older at menopause.

Conclusions. The molecular indices associated with breast cancer prognosis do not differ significantly among


๐Ÿ“œ SIMILAR VOLUMES


Ethnic differences in risk and prognosis
โœ Miguel A. Sanchez ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 158 KB ๐Ÿ‘ 2 views

provide little or no support of his concept. These include 1 ) the 1969 AFIP Fascicle on Tumors of the Peripheral Nervous System by Harkin and Reed,g wherein the term cellular schwannoma was used to denote a benign schwannoma, one cellular, exhibiting pleomorphism, both Antoni-A and B tissue, and on

Ethnicity-related variation in breast ca
โœ Leslie Bernstein; Cayla R. Teal; Sue Joslyn; Jerome Wilson ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 138 KB ๐Ÿ‘ 2 views

## Background: A variety of factors are predictors of breast cancer risk. however, the studies conducted to establish these risk factors have rarely included african american women. the few studies with sufficient numbers of african-american women suggest that risk factors for breast cancer among a

Breast cancer: Is ethnicity an independe
โœ Penny Perkins; Catherine D. Cooksley; James D. Cox ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 533 KB

A survival difference between white and black females has been reported after diagnosis and treatment for breast carcinoma. Although multivariate analyses demonstrate that the survival difference is less or nonexistent when additional prognostic factors are considered, study results have been incons

Prognostic factors in breast cancer
โœ M. K. Palmer; Mr. J. P. Lythgoe; Alwyn Smith ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 195 KB ๐Ÿ‘ 2 views
Ethnic differences in cancer risk result
โœ Susan L. Neuhausen ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB ๐Ÿ‘ 2 views

Ethnic differences in cancer incidence and mortality exist and are probably the result of genetic and epidemiological risk factors. Genetic differences caused by founder mutations are reviewed, with special emphasis on mutations in BRCA1 and BRCA2. Germline mutations in cancer susceptibility genes h